Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: PD-1 Inhibitors Maintenance for cHL Post-autoHCT [Phase 2]
Phase 2 trial assessing maintenance PD-1 inhibitors in classical Hodgkin lymphoma after autologous stem cell transplant; currently recruitin…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Breast Cancer Risk Investigation in Grown-up Hodgkin Lymphoma Patients Treated With MBVD. Multicenter Retrospective Study on ≥200 Adult Female HL Patients Treated With ≥1 MBVD Cycle (NPLD, Bleomycin, Vinblastine, Dacarbazine). It Investigates Breast Cancer Incidence Post-treatment.
This multicenter retrospective study evaluates the incidence of breast cancer in adult female Hodgkin lymphoma survivors treated with MBVD (…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG [NA]
A clinical trial investigating early detection of anthracycline cardiotoxicity risk in lymphoma patients using TEP/CT-FDG imaging, currently…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion [Phase 2]
A Phase 2 clinical trial evaluating allogeneic stem cell transplantation with alpha/beta T cell and CD19+ B cell depletion for malignant and…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma [Phase 3]
Ongoing Phase 3 clinical trial evaluating combination chemotherapy with or without radiation therapy in Hodgkin lymphoma, sponsored by the E…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma [Phase 3]
Phase 3 trial evaluating radiation therapy with or without combination chemotherapy in previously untreated stage I-II Hodgkin lymphoma.
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30) [Phase 1]
Phase 1 clinical trial of CD30-directed CAR T cells for relapsed CD30-expressing Hodgkin lymphoma and non-Hodgkin lymphoma is currently recr…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling [Phase 1]
Phase 1 clinical trial evaluating ex vivo drug sensitivity testing and multi-omics profiling in pediatric cancers. Recruitment is ongoing ac…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma [NA]
This clinical trial update covers a study of Brentuximab Vedotin in combination with AVD chemotherapy for newly diagnosed early-stage, unfav…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant [Phase 2]
A Phase II randomized trial evaluating hyperbaric oxygen to improve engraftment after umbilical cord blood stem cell transplantation in pati…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma [Phase 1]
Phase 1 clinical trial investigating tumor-associated antigen-specific T cells (TAA-T) in combination with a PD-1 inhibitor for Hodgkin lymp…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial evaluating pembrolizumab plus BEAM conditioning with autologous stem cell transplant for relapsed Hodgkin lymphoma. T…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing
An ongoing clinical trial update describes using phased variant analysis with next-generation sequencing to enable early assessment of lymph…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma [Phase 2]
Phase 2 clinical trial evaluating chemoradiotherapy with targeted immunotherapy for pediatric lymphomas. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Brentuximab Vedotin With or Without Nivolumab in Treating Patients With Relapsed or Refractory CD30+ Lymphoma [Phase 2]
Clinical trial update for a Phase 2 study evaluating brentuximab vedotin with or without nivolumab in patients with relapsed or refractory C…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma [Phase 2]
A Phase 2 clinical trial is evaluating isatuximab during stem cell collection and subsequent transplant in patients with multiple myeloma an…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL [Phase 1]
Phase 1 study of TAA-specific cytotoxic T lymphocytes (TACTAL) for Hodgkin lymphoma and non-Hodgkin lymphoma; the trial is currently active …
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis [Phase 2]
A Phase 2 trial (ABBA CORD) evaluating donor-derived cord blood T cells with abatacept for prophylaxis of acute graft-versus-host disease in…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
An ongoing clinical trial is evaluating whether dexrazoxane hydrochloride affects biomarkers linked to cardiomyopathy and heart failure afte…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III
A prospective cohort study on lymphoma sponsored by Samsung Medical Center is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Early Ageing During Therapy in AYA Cancer Patients
A clinical trial investigating early ageing during therapy in adolescents and young adults with cancer is currently recruiting. The study co…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: Pembrolizumab and Involved Site Radiation Therapy for Early Stage Relapsed or Primary Refractory Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating pembrolizumab with involved-site radiation therapy for early-stage relapsed or primary refractory Hodgki…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment [Phase 2]
Phase 2 trial evaluating autologous hematopoietic stem cell transplantation in children with relapsed or refractory Hodgkin lymphoma after n…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Phase II Trial of BrECADD in HIV-Positive Patients With Advanced-Stage Classical Hodgkin Lymphoma [Phase 2]
Phase II trial investigating BrECADD in HIV-positive patients with advanced classical Hodgkin lymphoma; status not yet recruiting.
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Pembrolizumab in First-Line Treatment of Advanced-Stage Classical Hodgkin Lymphoma [Phase 2]
An update on a Phase 2 trial of pembrolizumab as first-line treatment for advanced-stage classical Hodgkin lymphoma. The study is currently …